5028-20-6

Basic information

• Product Name: N2-METHYL-PYRIDINE-2,3-DIAMINE
• Synonyms: IFLAB-BB F2113-0168;N~2~-Methyl-2,3-pyridinediaMine (SALTDATA: FREE);N2-METHYL-PYRIDINE-2,3-DIAMINE;2-N-METHYLPYRIDINE-2,3-DIAMINE
• CAS NO: 5028-20-6
• Molecular Formula: C₆H₉N₃
• Molecular Weight: 123.15576
• Mol File: 5028-20-6.mol
• Article Data: 23

Chemical Properties

• Melting Point: 100-101 °C
• Boiling Point: 303.553 °C at 760 mmHg
• Flash Point: 137.384 °C
• Appearance: /
• Density: 1.18 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.652
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 7.04±0.10(Predicted)
• CAS DataBase Reference: N2-METHYL-PYRIDINE-2,3-DIAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: N2-METHYL-PYRIDINE-2,3-DIAMINE(5028-20-6)
• EPA Substance Registry System: N2-METHYL-PYRIDINE-2,3-DIAMINE(5028-20-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 5028-20-6(Hazardous Substances Data)

Usage

Uses

N2-Methylpyridine-2,3-diamine is a useful reagent in synthesis of imidazopyridines, which show tuberculostatic activity.

InChI:InChI=1/C6H9N3/c1-8-6-5(7)3-2-4-9-6/h2-4H,7H2,1H3,(H,8,9)

Upstream product

• 4093-88-3 2-(methylamino)-3-nitropyridine 
• 99315-00-1 (3-Amino-pyridin-2-yl)-carbamic acid methyl ester 
• 7440-05-3 palladium 
• 1281006-64-1 N-benzyl-N-methyl-3-nitropyridin-2-amine 
• 5470-18-8 2-Chloro-3-nitropyridine 
• 462-08-8 pyridin-3-ylamine 
• 99314-91-7 N²,N³-dibenzyloxycarbonyl-2,3-diaminopyridine 
• 99314-95-1 N³-benzyloxycarbonyl-N²-methoxycarbonyl-2,3-diaminopyridine 
• 99314-92-8 N²-amino-N³-benzyloxycarbonylaminopyridine 
• 452-58-4 2,3-Diaminopyridine 
• 1480-87-1 2-fluoro-3-nitropyridine 
• 6298-19-7 2-chloro-3-aminopyridine 
• 74-89-5 methylamine 

Downstream Products

• 1471-86-9 2-carbethoxy-4-methylpyrido<2,3-b>pyrazin-3(4H)-one 
• 123494-89-3 3-(3-Methyl-3H-2-imidazo<4,5-b>pyridine)propionic acid 
• 1399050-32-8 N₂-methyl-N₃-phenylpyridine-2,3-diamine 
• 30458-69-6 3-methyl-3H-imidazo[4,5-b]pyridin-2-amine 
• 50339-06-5 1-methyl-1,3-dihydro-2H-imidazo<4,5-b>pyridin-2-one 
• 80708-25-4 4-methyl-1,4-dihydropyrido[2,3-b]piperazine-2,3-dione 
• 21991-39-9 3-methyl-1,3-dihydro-imidazo[4,5-b]pyridin-2-one 
• 30458-68-5 2-chloro-3-methyl-3H-imidazo[4,5-b]pyridine 
• 6688-61-5 3-methyl-3H-imidazo[4,5-b]pyridine 
• 1401817-89-7 2-(4-methoxyphenyl)-3-methyl-3H-imidazo[4,5-b]pyridine 
• 1097725-72-8 3-methyl-2-N-(p-toluenesulfonyl)aminoimidazo[4,5-b]pyridine 
• 41231-05-4 2,3-Dimethylimidazo<4,5-b>pyridine 
• 133465-77-7 (3-Methyl-3H-imidazo[4,5-b]pyridin-2-yl)-acetic acid [1-(3,4-dimethoxy-phenyl)-meth-(E)-ylidene]-hydrazide 
• 133465-78-8 (3-Methyl-3H-imidazo[4,5-b]pyridin-2-yl)-acetic acid [1-(4-hydroxy-3-methoxy-phenyl)-meth-(E)-ylidene]-hydrazide 

Relevant articles and documents

Novel imidazo[4,5-b]pyridine derived acrylonitriles: A combined experimental and computational study of their antioxidative potential

We describe the synthesis of novel unsubstituted and N-substituted imidazo[4,5-b]pyridine derived acrylonitriles, which were prepared by classical and microwave assisted organic synthesis. Their antioxidative potential was studied using spectroscopic DPPH

SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted benzimidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

5,10-Dihydropyrido-pyrazolo-triazine compounds and application thereof

The invention relates to 5,10-dihydropyrido[2',3':5,6]pyrazolo[2,3-e][1,2,4]triazine compounds shown in general formula I, and their optical activators or racemates or their pharmaceutically acceptable salts, hydrates or solvates, wherein substituents R1,